Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: A consensus statement

Peter Nash, Andreas Kerschbaumer, Thomas Dörner, Maxime Dougados, Roy M. Fleischmann, Klaus Geissler, Iain McInnes, Janet E. Pope, Désirée Van Der Heijde, Michaela Stoffer-Marx, Tsutomu Takeuchi, Michael Trauner, Kevin L. Winthrop, Maarten De Wit, Daniel Aletaha, Xenofon Baraliakos, Wolf Henning Boehncke, Paul Emery, John D. Isaacs, Joel KremerEun Bong Lee, Walter P. Maksymowych, Marieke Voshaar, Lai Shan Tam, Yoshiya Tanaka, Filip Van Den Bosch, René Westhovens, Ricardo Xavier, Josef S. Smolen

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations

Fingerprint Dive into the research topics of 'Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: A consensus statement'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds